215 related articles for article (PubMed ID: 31213631)
1. Rosmarinic acid suppresses Alzheimer's disease development by reducing amyloid β aggregation by increasing monoamine secretion.
Hase T; Shishido S; Yamamoto S; Yamashita R; Nukima H; Taira S; Toyoda T; Abe K; Hamaguchi T; Ono K; Noguchi-Shinohara M; Yamada M; Kobayashi S
Sci Rep; 2019 Jun; 9(1):8711. PubMed ID: 31213631
[TBL] [Abstract][Full Text] [Related]
2. Phenolic compounds prevent Alzheimer's pathology through different effects on the amyloid-beta aggregation pathway.
Hamaguchi T; Ono K; Murase A; Yamada M
Am J Pathol; 2009 Dec; 175(6):2557-65. PubMed ID: 19893028
[TBL] [Abstract][Full Text] [Related]
3. Rosmarinic acid and caffeic acid produce antidepressive-like effect in the forced swimming test in mice.
Takeda H; Tsuji M; Inazu M; Egashira T; Matsumiya T
Eur J Pharmacol; 2002 Aug; 449(3):261-7. PubMed ID: 12167468
[TBL] [Abstract][Full Text] [Related]
4. Dietary Intake of Rosmarinic Acid Increases Serum Inhibitory Activity in Amyloid A Aggregation and Suppresses Deposition in the Organs of Mice.
Lin X; Watanabe K; Kuragano M; Kurotaki Y; Nakanishi U; Tokuraku K
Int J Mol Sci; 2020 Aug; 21(17):. PubMed ID: 32825797
[TBL] [Abstract][Full Text] [Related]
5. Structure-activity relations of rosmarinic acid derivatives for the amyloid β aggregation inhibition and antioxidant properties.
Taguchi R; Hatayama K; Takahashi T; Hayashi T; Sato Y; Sato D; Ohta K; Nakano H; Seki C; Endo Y; Tokuraku K; Uwai K
Eur J Med Chem; 2017 Sep; 138():1066-1075. PubMed ID: 28759879
[TBL] [Abstract][Full Text] [Related]
6. Molecular Pharmacology of Rosmarinic and Salvianolic Acids: Potential Seeds for Alzheimer's and Vascular Dementia Drugs.
Habtemariam S
Int J Mol Sci; 2018 Feb; 19(2):. PubMed ID: 29401682
[TBL] [Abstract][Full Text] [Related]
7. Phenolic compounds prevent amyloid β-protein oligomerization and synaptic dysfunction by site-specific binding.
Ono K; Li L; Takamura Y; Yoshiike Y; Zhu L; Han F; Mao X; Ikeda T; Takasaki J; Nishijo H; Takashima A; Teplow DB; Zagorski MG; Yamada M
J Biol Chem; 2012 Apr; 287(18):14631-43. PubMed ID: 22393064
[TBL] [Abstract][Full Text] [Related]
8. Monoamine oxidase B is elevated in Alzheimer disease neurons, is associated with γ-secretase and regulates neuronal amyloid β-peptide levels.
Schedin-Weiss S; Inoue M; Hromadkova L; Teranishi Y; Yamamoto NG; Wiehager B; Bogdanovic N; Winblad B; Sandebring-Matton A; Frykman S; Tjernberg LO
Alzheimers Res Ther; 2017 Aug; 9(1):57. PubMed ID: 28764767
[TBL] [Abstract][Full Text] [Related]
9. Curcumin derivative with the substitution at C-4 position, but not curcumin, is effective against amyloid pathology in APP/PS1 mice.
Yanagisawa D; Ibrahim NF; Taguchi H; Morikawa S; Hirao K; Shirai N; Sogabe T; Tooyama I
Neurobiol Aging; 2015 Jan; 36(1):201-10. PubMed ID: 25179227
[TBL] [Abstract][Full Text] [Related]
10. Spearmint Extract Containing Rosmarinic Acid Suppresses Amyloid Fibril Formation of Proteins Associated with Dementia.
Ogawa K; Ishii A; Shindo A; Hongo K; Mizobata T; Sogon T; Kawata Y
Nutrients; 2020 Nov; 12(11):. PubMed ID: 33202830
[TBL] [Abstract][Full Text] [Related]
11. Determination of monoamines and both forms of monoamine oxidase in the rat's substantia nigra during postnatal development.
Venero JL; Santiago M; Machado A; Cano J
Life Sci; 1989; 45(14):1277-83. PubMed ID: 2811598
[TBL] [Abstract][Full Text] [Related]
12. Natural Phenolic Compounds as Therapeutic and Preventive Agents for Cerebral Amyloidosis.
Yamada M; Ono K; Hamaguchi T; Noguchi-Shinohara M
Adv Exp Med Biol; 2015; 863():79-94. PubMed ID: 26092627
[TBL] [Abstract][Full Text] [Related]
13. Rosmarinic acid attenuates β-amyloid-induced oxidative stress via Akt/GSK-3β/Fyn-mediated Nrf2 activation in PC12 cells.
Rong H; Liang Y; Niu Y
Free Radic Biol Med; 2018 May; 120():114-123. PubMed ID: 29555592
[TBL] [Abstract][Full Text] [Related]
14. Depressive-like behavior is paired to monoaminergic alteration in a murine model of Alzheimer's disease.
Romano A; Pace L; Tempesta B; Lavecchia AM; Macheda T; Bedse G; Petrella A; Cifani C; Serviddio G; Vendemiale G; Gaetani S; Cassano T
Int J Neuropsychopharmacol; 2014 Oct; 18(4):. PubMed ID: 25609597
[TBL] [Abstract][Full Text] [Related]
15. Effect of aging and Alzheimer's disease-like pathology on brain monoamines in mice.
Von Linstow CU; Severino M; Metaxas A; Waider J; Babcock AA; Lesch KP; Gramsbergen JB; Finsen B
Neurochem Int; 2017 Sep; 108():238-245. PubMed ID: 28414094
[TBL] [Abstract][Full Text] [Related]
16. Effects of rosmarinic acid on cognitive and biochemical alterations in ovariectomized rats treated with D-galactose.
Kantar Gok D; Ozturk N; Er H; Aslan M; Demir N; Derin N; Agar A; Yargicoglu P
Folia Histochem Cytobiol; 2015; 53(4):283-93. PubMed ID: 26714446
[TBL] [Abstract][Full Text] [Related]
17. Amyloid-beta (Aβ₁₋₄₂)-induced paralysis in Caenorhabditis elegans is inhibited by the polyphenol quercetin through activation of protein degradation pathways.
Regitz C; Dußling LM; Wenzel U
Mol Nutr Food Res; 2014 Oct; 58(10):1931-40. PubMed ID: 25066301
[TBL] [Abstract][Full Text] [Related]
18. Neurochemical characterization of the release and uptake of dopamine in ventral tegmental area and serotonin in substantia nigra of the mouse.
John CE; Budygin EA; Mateo Y; Jones SR
J Neurochem; 2006 Jan; 96(1):267-82. PubMed ID: 16300629
[TBL] [Abstract][Full Text] [Related]
19. Plant-derived neurotoxic amino acids (beta-N-oxalylamino-L-alanine and beta-N-methylamino-L-alanine): effects on central monoamine neurons.
Lindström H; Luthman J; Mouton P; Spencer P; Olson L
J Neurochem; 1990 Sep; 55(3):941-9. PubMed ID: 1974606
[TBL] [Abstract][Full Text] [Related]
20. Rosmarinic acid- and curcumin-loaded polyacrylamide-cardiolipin-poly(lactide-co-glycolide) nanoparticles with conjugated 83-14 monoclonal antibody to protect β-amyloid-insulted neurons.
Kuo YC; Tsai HC
Mater Sci Eng C Mater Biol Appl; 2018 Oct; 91():445-457. PubMed ID: 30033276
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
